GlassScriptPhysician profile
Nader Y Abdelsayed
NPI 1972554756
$3,540.31
in general payments reported to CMS, 2019-2025
29 companies · $441 in 2025
The $441 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $715 · 2020: $352 · 2021: $545 · 2022: $648 · 2023: $494 · 2024: $345 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,074 · Education: $206.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,074.45 |
| Education | $206.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $840.07 | 2019-2022 | |
| Daiichi Sankyo INC. | $676.43 | 2019-2025 | Injectafer |
| Astellas Pharma US INC | $439.84 | 2023-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $196.91 | 2019-2025 | Acessa Provu System, Aptima |
| Applied Medical Resources Corporation | $146.56 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $135.09 | 2022 | |
| Biogen, INC. | $125.00 | 2025 | Zurzuvae |
| Pfizer INC. | $124.73 | 2019-2025 | |
| Boston Scientific Corporation | $121.33 | 2019-2023 | |
| Minerva Surgical, INC | $109.93 | 2019 | |
| Optumhealth Care Solutions, LLC | $90.76 | 2023 | Vivify Health Care Team Portal |
| Pacira Pharmaceuticals Incorporated | $85.61 | 2025 | Exparel |
| Bayer Healthcare Pharmaceuticals INC. | $72.84 | 2021-2025 | |
| Allergan, INC. | $61.39 | 2019-2020 | |
| Exeltis, USA INC. | $53.51 | 2022-2024 | Slynd |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $45.64 | 2019-2020 | |
| Momentis Surgical INC. | $33.00 | 2022 | |
| Lupin INC. | $31.25 | 2019-2020 | |
| Mylan Pharmaceuticals INC. | $30.39 | 2021 | |
| Therapeuticsmd, INC. | $24.21 | 2022 | |
| Aspira Women'S Health INC | $24.18 | 2024 | Ova1 |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.28 | 2022 | |
| Sage Therapeutics, LLC | $14.17 | 2025 | Zurzuvae |
| Supernus Pharmaceuticals, INC. | $14.17 | 2025 | Qelbree |
| Organon LLC | $12.76 | 2025 | Jada System |
| Dysis Medical, INC. | $11.26 | 2019 |
3 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nader Abdelsayed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.